3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
7
Sarcoma
3
Liposarcoma, Myxoid
3
Sarcoma, Synovial
2
Prostatic Neoplasms
2
Neurofibrosarcoma
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thymoma
1
Small Cell Lung Cancer Limited Stage
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Radiotherapy; Complications
1
Radiation Injuries
1
Neoplasm Metastasis
1
Myosarcoma
1
Lymphangiosarcoma
1
Lung Neoplasms
1
Limited Stage Small Cell Lung Cancer
1
Hyperthermia
1
Histiocytic Sarcoma
1
Endometrial Neoplasms
1
Dermatofibrosarcoma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Carcinoma In Situ
1
Interventions
anlotinib
1
Radiation Dose Hypofractionation
1
Etoposide
1
Cisplatin
1
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Small Cell Lung Cancer Limited Stage
×
Radiation Dose Hypofractionation
×
Clear all
NCT04543890
2020-09-10
CTV
Zhejiang Cancer Hospital
Phase 2
Unknown
300 enrolled